| Line Item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Profit or loss [abstract] | |||||||||
| Net sales | |||||||||
| Other operating revenues | |||||||||
| Total revenues | |||||||||
| Cost of goods sold | |||||||||
| Gross profit | |||||||||
| Administrative expenses | |||||||||
| Selling expenses | |||||||||
| Other income | |||||||||
| Other expenses | |||||||||
| Interest expense | |||||||||
| Interest income | |||||||||
| Foreign exchange loss (gain) , net | |||||||||
| Gain on monetary position for subsidiaries in hyperinflationary economies | |||||||||
| Market value (gain) loss on financial instruments | |||||||||
| Income before income taxes and share in the profit of equity method accounted investees | |||||||||
| Income taxes | |||||||||
| Share in the loss of equity method accounted investees | |||||||||
| Net income from continuing operations | |||||||||
| Net income from discontinued operations | |||||||||
| CONSOLIDATED NET INCOME | |||||||||
| Non-controlling interest |